HY-TISSUE MICROGRAFT TECHNOLOGY
DEAD

Serial Number

79310677

Owner

Fidia Farmaceutici S.p.a.

Filing Date

Feb 12, 2021

Add to watchlist:

No watchlists yet
View on USPTO

HY-TISSUE MICROGRAFT TECHNOLOGY Trademark

Serial Number: 79310677

HY-TISSUE MICROGRAFT TECHNOLOGY is a trademark filed by Fidia Farmaceutici S.p.a. on February 12, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently no longer active.

Owner Contact Info

Fidia Farmaceutici S.p.a. (93 trademarks)

Via Ponte della Fabbrica 3, A
Abano Terme I-35031 , IT

Entity Type: 09

Trademark Details

Filing Date

February 12, 2021

Registration Date

Not Registered

Goods & Services

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; blood plasma; anticoagulants, diagnostic preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes; food for babies; dietary supplements for humans and animals; plasters, materials for dressings; material for stopping teeth and for dental impressions; disinfectants; fungicides; medicines; medical preparations for the prevention, control, therapy or mitigation of a disease or wound; dermocosmetic preparations for medicinal or surgical purposes; dermatological preparations; dermatological preparations for the treatment and care of chronic ulcers; dermal tissues for the treatment of burns; tissues or gauzes impregnated with antibacterial substances; pharmaceutical creams and lotions; creams, sprays, lotions, gels or ointments for dermatological purposes, wound care and tissue repair; nutraceutical preparations for use as dietary supplements; mineral, vitamin, dietary and nutritional supplements; nutritional dietary supplements; protein dietary supplements; mineral and vitamin food supplements; vitamins and minerals for medical or veterinary purposes; food additives for veterinary or medical purposes; nutritional and dietetic additives for veterinary or medical purposes; antioxidants, vitamins, mineral or oligo-elements as single or associated ingredients for the preparation of foodstuffs or nutritional supplements; parapharmaceutical preparations for dermatological use

Medical and veterinary devices; medical and surgical, medical and veterinary apparatus and instruments; diagnostic apparatus for medical, cosmetic and veterinary purposes; apparatus and instruments for separating human and animal tissues and cells; devices for disaggregation of biological material for preparing cell suspensions and micro-insert of tissue; apparatus and instruments used in laboratories of microbiology for the processing of biological material; medical laboratory equipment for processing tissue samples; medical devices for the care of diseases concerning human tissues and for veterinary medicine; blood testing apparatus; cannulas; catheters; diagnostic devices for medical purposes; hemocytometers; hypodermic syringes; injectors for medical use; injection needles; syringes for injection; glass tubes for medical purposes; centrifuges for medical use; kits comprising apparatus for blood collection, separation of blood components, treatment of blood and reinjection of blood for medical purposes; orthopedic articles; suture materials; applicators and devices for the administration of pharmaceutical, cosmetic and dermocosmetic products for medical purposes

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
May 9, 2023 FINT
FINAL DISPOSITION NOTICE SENT TO IB
Apr 14, 2023 FICS
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 14, 2023 FICR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Nov 7, 2022 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Oct 19, 2022 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Oct 19, 2022 OPNR
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Apr 14, 2022 MAB2
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Apr 14, 2022 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Apr 14, 2022 ABN2
REFUSAL PROCESSED BY IB
Oct 30, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 1, 2021 RFCS
REFUSAL PROCESSED BY MPU
Sep 30, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 15, 2021 RFCR
NON-FINAL ACTION WRITTEN
Sep 14, 2021 CNRT
ASSIGNED TO EXAMINER
Sep 9, 2021 DOCK
APPLICATION FILING RECEIPT MAILED
May 21, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 17, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
May 13, 2021 REPR